BofA Securities resumed coverage on Cardlytics with a new price target
$CDLX
Computer Software: Programming Data Processing
Technology
BofA Securities resumed coverage of Cardlytics with a rating of Neutral and set a new price target of $11.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | $4.00 | In-line | Evercore ISI |
| 8/16/2024 | $5.00 | Outperform → Market Perform | Northland Capital |
| 8/15/2024 | $4.00 → $3.50 | Neutral → Underperform | BofA Securities |
| 8/8/2024 | Buy → Hold | Craig Hallum | |
| 8/8/2024 | Buy → Hold | Needham | |
| 8/8/2024 | $18.00 → $5.00 | Buy → Hold | Lake Street |
| 6/20/2024 | $11.00 | Neutral | BofA Securities |
| 6/18/2024 | $14.00 | Outperform | Northland Capital |